Literature DB >> 21349950

The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.

Tara A van de Water1, Hendrik P Bijl, Cornelis Schilstra, Madelon Pijls-Johannesma, Johannes A Langendijk.   

Abstract

PURPOSE: Clinical studies concerning head and neck cancer patients treated with protons reporting on radiation-induced side effects are scarce. Therefore, we reviewed the literature regarding the potential benefits of protons compared with the currently used photons in terms of lower doses to normal tissue and the potential for fewer subsequent radiation-induced side effects, with the main focus on in silico planning comparative (ISPC) studies.
MATERIALS AND METHODS: A literature search was performed by two independent researchers on ISPC studies that included proton-based and photon-based irradiation techniques.
RESULTS: Initially, 877 papers were retrieved and 14 relevant and eligible ISPC studies were identified and included in this review. Four studies included paranasal sinus cancer cases, three included nasopharyngeal cancer cases, and seven included oropharyngeal, hypopharyngeal, and/or laryngeal cancer cases. Seven studies compared the most sophisticated photon and proton techniques: intensity-modulated photon therapy versus intensity-modulated proton therapy (IMPT). Four studies compared different proton techniques. All studies showed that protons had a lower normal tissue dose, while keeping similar or better target coverage. Two studies found that these lower doses theoretically translated into a significantly lower incidence of salivary dysfunction.
CONCLUSION: The results of ISPC studies indicate that protons have the potential for a significantly lower normal tissue dose, while keeping similar or better target coverage. Scanned IMPT probably offers the most advantage and will allow for a substantially lower probability of radiation-induced side effects. The results of these ISPC studies should be confirmed in properly designed clinical trials.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349950      PMCID: PMC3228110          DOI: 10.1634/theoncologist.2010-0171

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  36 in total

1.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.

Authors:  A Eisbruch; R K Ten Haken; H M Kim; L H Marsh; J A Ship
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-10-01       Impact factor: 7.038

2.  The relative costs of proton and X-ray radiation therapy.

Authors:  M Goitein; M Jermann
Journal:  Clin Oncol (R Coll Radiol)       Date:  2003-02       Impact factor: 4.126

3.  Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma.

Authors:  Ulrike Mock; Dietmar Georg; Joachim Bogner; Thomas Auberger; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-01-01       Impact factor: 7.038

4.  Potential improvement of three dimension treatment planning and proton therapy in the outcome of maxillary sinus cancer.

Authors:  R Miralbell; C Crowell; H D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

5.  The simultaneous integrated boost with proton beams in head and neck patients.

Authors:  Luca Cozzia; Alessandra Bolsi; Giorgia Nicolini; Antonella Fogliata
Journal:  Z Med Phys       Date:  2004       Impact factor: 4.820

6.  Fitting of normal tissue tolerance data to an analytic function.

Authors:  C Burman; G J Kutcher; B Emami; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

Review 7.  Tolerance of normal tissue to therapeutic irradiation.

Authors:  B Emami; J Lyman; A Brown; L Coia; M Goitein; J E Munzenrider; B Shank; L J Solin; M Wesson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-05-15       Impact factor: 7.038

8.  Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning.

Authors:  A P Brown; M M Urie; R Chisin; H D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

9.  Carcinoma of the tonsillar region: potential for use of proton beam therapy.

Authors:  J M Slater; J D Slater; J O Archambeau
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

10.  Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.

Authors:  Jonas Johansson; Erik Blomquist; Anders Montelius; Ulf Isacsson; Bengt Glimelius
Journal:  Radiother Oncol       Date:  2004-08       Impact factor: 6.280

View more
  40 in total

Review 1.  [Tumors of the paranasal sinus invading the orbit].

Authors:  M Herzog
Journal:  HNO       Date:  2018-10       Impact factor: 1.284

Review 2.  Treatment planning optimisation in proton therapy.

Authors:  S E McGowan; N G Burnet; A J Lomax
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

3.  Technical Note: A treatment plan comparison between dynamic collimation and a fixed aperture during spot scanning proton therapy for brain treatment.

Authors:  Blake Smith; Edgar Gelover; Alexandra Moignier; Dongxu Wang; Ryan T Flynn; Liyong Lin; Maura Kirk; Tim Solberg; Daniel E Hyer
Journal:  Med Phys       Date:  2016-08       Impact factor: 4.071

4.  Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.

Authors:  Steven J Frank; James D Cox; Michael Gillin; Radhe Mohan; Adam S Garden; David I Rosenthal; G Brandon Gunn; Randal S Weber; Merrill S Kies; Jan S Lewin; Mark F Munsell; Matthew B Palmer; Narayan Sahoo; Xiaodong Zhang; Wei Liu; X Ronald Zhu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-24       Impact factor: 7.038

Review 5.  Multimodal Therapy for Sinonasal Malignancies: Updates and Review of Current Treatment.

Authors:  Mayur D Mody; Nabil F Saba
Journal:  Curr Treat Options Oncol       Date:  2020-01-16

Review 6.  Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.

Authors:  Steven B Chinn; Jeffrey N Myers
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

7.  Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.

Authors:  Wencheng Zhang; Xiaodong Zhang; Pei Yang; Pierre Blanchard; Adam S Garden; Brandon Gunn; C David Fuller; Mark Chambers; Katherine A Hutcheson; Rong Ye; Stephen Y Lai; Mohamed Abdallah Sherif Radwan; X Ron Zhu; Steven J Frank
Journal:  Radiother Oncol       Date:  2017-05-23       Impact factor: 6.280

Review 8.  Charged particle therapy--optimization, challenges and future directions.

Authors:  Jay S Loeffler; Marco Durante
Journal:  Nat Rev Clin Oncol       Date:  2013-05-21       Impact factor: 66.675

9.  Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.

Authors:  Marc W Herr; Rosh K V Sethi; Joshua C Meier; Kyle J Chambers; Aaron Remenschneider; Annie Chan; William T Curry; Fred G Barker; Daniel G Deschler; Derrick T Lin
Journal:  J Neurol Surg B Skull Base       Date:  2013-09-20

Review 10.  Reduced radiation-induced toxicity by using proton therapy for the treatment of oropharyngeal cancer.

Authors:  Tineke W H Meijer; Dan Scandurra; Johannes A Langendijk
Journal:  Br J Radiol       Date:  2020-01-30       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.